vs
Alkermes plc.（ALKS）与Cloudflare, Inc.（NET）财务数据对比。点击上方公司名可切换其他公司
Cloudflare, Inc.的季度营收约是Alkermes plc.的1.6倍（$614.5M vs $384.5M），Alkermes plc.净利率更高（12.8% vs -2.0%，领先14.8%），Cloudflare, Inc.同比增速更快（33.6% vs -10.6%），Alkermes plc.自由现金流更多（$170.0M vs $105.2M），过去两年Cloudflare, Inc.的营收复合增速更高（27.4% vs 4.8%）
Alkermes plc是一家全产业链布局的生物制药企业，专注于精神障碍与神经系统疾病相关药物的研发。公司1987年由迈克尔·沃尔创立，2011年9月与原Élan集团旗下的药物制剂及生产部门Elan Drug Technologies合并，总部位于都柏林，在马萨诸塞州沃尔瑟姆设有研发中心，俄亥俄州威尔明顿建有生产基地。
Cloudflare是总部位于美国加利福尼亚州旧金山的科技企业，提供内容分发网络（CDN）、云网络安全、DDoS防护等多元互联网服务，同时是ICANN认证的域名注册商。其服务作为网站访客与客户托管服务商之间的反向代理，可有效提升访问性能，抵御恶意流量。
ALKS vs NET — 直观对比
营收规模更大
NET
是对方的1.6倍
$384.5M
营收增速更快
NET
高出44.2%
-10.6%
净利率更高
ALKS
高出14.8%
-2.0%
自由现金流更多
ALKS
多$64.8M
$105.2M
两年增速更快
NET
近两年复合增速
4.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $384.5M | $614.5M |
| 净利润 | $49.3M | $-12.1M |
| 毛利率 | 88.0% | 73.6% |
| 营业利润率 | 15.1% | -8.0% |
| 净利率 | 12.8% | -2.0% |
| 营收同比 | -10.6% | 33.6% |
| 净利润同比 | -66.3% | 6.0% |
| 每股收益（稀释后） | $0.29 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALKSNET
| Q4 25 | $384.5M | $614.5M | ||
| Q3 25 | $394.2M | $562.0M | ||
| Q2 25 | $390.7M | $512.3M | ||
| Q1 25 | $306.5M | $479.1M | ||
| Q4 24 | $430.0M | $459.9M | ||
| Q3 24 | $378.1M | $430.1M | ||
| Q2 24 | $399.1M | $401.0M | ||
| Q1 24 | $350.4M | $378.6M |
净利润ALKSNET
| Q4 25 | $49.3M | $-12.1M | ||
| Q3 25 | $82.8M | $-1.3M | ||
| Q2 25 | $87.1M | $-50.4M | ||
| Q1 25 | $22.5M | $-38.5M | ||
| Q4 24 | $146.5M | $-12.8M | ||
| Q3 24 | $92.4M | $-15.3M | ||
| Q2 24 | $91.4M | $-15.1M | ||
| Q1 24 | $36.8M | $-35.5M |
毛利率ALKSNET
| Q4 25 | 88.0% | 73.6% | ||
| Q3 25 | 86.9% | 74.0% | ||
| Q2 25 | 87.3% | 74.9% | ||
| Q1 25 | 83.9% | 75.9% | ||
| Q4 24 | 85.6% | 76.4% | ||
| Q3 24 | 83.3% | 77.7% | ||
| Q2 24 | 84.6% | 77.8% | ||
| Q1 24 | 83.3% | 77.5% |
营业利润率ALKSNET
| Q4 25 | 15.1% | -8.0% | ||
| Q3 25 | 22.6% | -6.7% | ||
| Q2 25 | 23.8% | -13.1% | ||
| Q1 25 | 4.5% | -11.1% | ||
| Q4 24 | 37.8% | -7.5% | ||
| Q3 24 | 27.7% | -7.2% | ||
| Q2 24 | 27.5% | -8.7% | ||
| Q1 24 | 12.4% | -14.4% |
净利率ALKSNET
| Q4 25 | 12.8% | -2.0% | ||
| Q3 25 | 21.0% | -0.2% | ||
| Q2 25 | 22.3% | -9.8% | ||
| Q1 25 | 7.3% | -8.0% | ||
| Q4 24 | 34.1% | -2.8% | ||
| Q3 24 | 24.4% | -3.6% | ||
| Q2 24 | 22.9% | -3.8% | ||
| Q1 24 | 10.5% | -9.4% |
每股收益（稀释后）ALKSNET
| Q4 25 | $0.29 | $-0.03 | ||
| Q3 25 | $0.49 | $0.00 | ||
| Q2 25 | $0.52 | $-0.15 | ||
| Q1 25 | $0.13 | $-0.11 | ||
| Q4 24 | $0.88 | $-0.05 | ||
| Q3 24 | $0.55 | $-0.04 | ||
| Q2 24 | $0.53 | $-0.04 | ||
| Q1 24 | $0.21 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $388.6M | $943.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.8B | $1.5B |
| 总资产 | $2.5B | $6.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALKSNET
| Q4 25 | $388.6M | $943.5M | ||
| Q3 25 | $616.4M | $1.1B | ||
| Q2 25 | $521.2M | $1.5B | ||
| Q1 25 | $399.8M | $204.5M | ||
| Q4 24 | $291.1M | $147.7M | ||
| Q3 24 | $396.3M | $182.9M | ||
| Q2 24 | $535.1M | $157.0M | ||
| Q1 24 | $420.8M | $254.4M |
股东权益ALKSNET
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.5B | $1.0B | ||
| Q3 24 | $1.3B | $973.1M | ||
| Q2 24 | $1.3B | $881.5M | ||
| Q1 24 | $1.3B | $797.2M |
总资产ALKSNET
| Q4 25 | $2.5B | $6.0B | ||
| Q3 25 | $2.3B | $5.8B | ||
| Q2 25 | $2.3B | $5.6B | ||
| Q1 25 | $2.1B | $3.7B | ||
| Q4 24 | $2.1B | $3.3B | ||
| Q3 24 | $2.2B | $3.1B | ||
| Q2 24 | $2.2B | $2.9B | ||
| Q1 24 | $2.1B | $2.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.1M | $190.4M |
| 自由现金流经营现金流 - 资本支出 | $170.0M | $105.2M |
| 自由现金流率自由现金流/营收 | 44.2% | 17.1% |
| 资本支出强度资本支出/营收 | 0.0% | 13.9% |
| 现金转化率经营现金流/净利润 | 3.45× | — |
| 过去12个月自由现金流最近4个季度 | $480.3M | $287.5M |
8季度趋势，按日历期对齐
经营现金流ALKSNET
| Q4 25 | $170.1M | $190.4M | ||
| Q3 25 | $101.7M | $167.1M | ||
| Q2 25 | $150.2M | $99.8M | ||
| Q1 25 | $98.8M | $145.8M | ||
| Q4 24 | $190.4M | $127.3M | ||
| Q3 24 | $81.6M | $104.7M | ||
| Q2 24 | $146.0M | $74.8M | ||
| Q1 24 | $21.1M | $73.6M |
自由现金流ALKSNET
| Q4 25 | $170.0M | $105.2M | ||
| Q3 25 | $84.4M | $82.5M | ||
| Q2 25 | $137.2M | $39.9M | ||
| Q1 25 | $88.7M | $59.9M | ||
| Q4 24 | $180.6M | $54.2M | ||
| Q3 24 | $73.3M | $54.5M | ||
| Q2 24 | $138.9M | $45.2M | ||
| Q1 24 | $12.8M | $41.5M |
自由现金流率ALKSNET
| Q4 25 | 44.2% | 17.1% | ||
| Q3 25 | 21.4% | 14.7% | ||
| Q2 25 | 35.1% | 7.8% | ||
| Q1 25 | 28.9% | 12.5% | ||
| Q4 24 | 42.0% | 11.8% | ||
| Q3 24 | 19.4% | 12.7% | ||
| Q2 24 | 34.8% | 11.3% | ||
| Q1 24 | 3.6% | 11.0% |
资本支出强度ALKSNET
| Q4 25 | 0.0% | 13.9% | ||
| Q3 25 | 4.4% | 15.1% | ||
| Q2 25 | 3.3% | 11.7% | ||
| Q1 25 | 3.3% | 17.9% | ||
| Q4 24 | 2.3% | 15.9% | ||
| Q3 24 | 2.2% | 11.7% | ||
| Q2 24 | 1.8% | 7.4% | ||
| Q1 24 | 2.4% | 8.5% |
现金转化率ALKSNET
| Q4 25 | 3.45× | — | ||
| Q3 25 | 1.23× | — | ||
| Q2 25 | 1.72× | — | ||
| Q1 25 | 4.40× | — | ||
| Q4 24 | 1.30× | — | ||
| Q3 24 | 0.88× | — | ||
| Q2 24 | 1.60× | — | ||
| Q1 24 | 0.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALKS
| Vivitrol | $124.1M | 32% |
| Aristada And Aristada Initio | $97.2M | 25% |
| LYBALVI | $94.1M | 24% |
| Royalty | $65.7M | 17% |
| Manufacturing Revenue | $3.3M | 1% |
NET
| Sales Channel Directly To Consumer | $438.5M | 71% |
| Sales Channel Through Intermediary | $176.0M | 29% |
